Substrate having an electron donating surface with metal particles comprising palladium on said surface
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
B32B-005/16
B05D-001/12
출원번호
US-0674893
(2012-11-12)
등록번호
US-8765256
(2014-07-01)
발명자
/ 주소
Ohrlander, Mattias
Södervall, Billy
출원인 / 주소
Bactiguard AB
대리인 / 주소
Hiscock & Barclay, LLP
인용정보
피인용 횟수 :
2인용 특허 :
17
초록▼
A substrate is provided with a metal electron donating surface made up of metal particles on the substrate, the metal particles having palladium and at least one metal selected from gold, ruthenium, rhodium, osmium, iridium, or platinum. The amount of the metal particles present on the substrate is
A substrate is provided with a metal electron donating surface made up of metal particles on the substrate, the metal particles having palladium and at least one metal selected from gold, ruthenium, rhodium, osmium, iridium, or platinum. The amount of the metal particles present on the substrate is from about 0.001 to about 8 μg/cm2 and wherein the substrate is part of a device or object from aspects of the medical field.
대표청구항▼
1. A device comprising a substrate having an electron donating surface, wherein said electron donating surface comprises a metal selected from the group consisting of silver and zinc, wherein metal particles are deposited on said electron donating surface, said metal particles comprising palladium a
1. A device comprising a substrate having an electron donating surface, wherein said electron donating surface comprises a metal selected from the group consisting of silver and zinc, wherein metal particles are deposited on said electron donating surface, said metal particles comprising palladium and at least one metal selected from the group consisting of gold, ruthenium, rhodium, osmium, iridium, and platinum and wherein the amount of said metal particles is from 0.001 to about 8 μg/cm2, and wherein the metal particles do not form a covering layer, but are uniformly distributed particles or clusters on said electron donating surface. 2. The device according to claim 1, wherein said silver in said electron donating surface is present in an amount of about 0.05 to about 12 μg/cm2. 3. The device according to claim 1, wherein said substrate is a polymeric substrate. 4. The device according to claim 3, wherein said polymeric substrate is selected from the group consisting of latex, vinyl, polymers comprising vinyl groups, polyurethane urea, silicone, polyvinylchloride, polypropylene, styrene, polyurethane, polyester, copolymerisates of ethylene vinyl acetate, polystyrene, polycarbonate, polyethylene, polyacrylate, polymethacrylate, acrylonitrile butadiene styrene, polyamide, and polyimide, or mixtures thereof. 5. The device according to claim 1, wherein said substrate is formed from a metal. 6. The device according to claim 5, wherein said metal of said substrate is selected from the group consisting of stainless steel, medical grade steel, titanium, medical grade titanium, cobalt, and chromium or mixtures thereof. 7. The device according to claim 1, wherein said substrate is selected from the group consisting of glass, minerals, zeolites, stone and ceramics. 8. The device according to claim 1, wherein said substrate is selected from the group consisting of paper, wood, woven fibres, fibres, cellulose fibres, leather, carbon, carbon fibres, graphite, polytetrafluoroethylene, and polyparaphenyleneterephthalamide. 9. The device according to claim 1, wherein the amount of the metal particles of the metal deposited onto said metal electron donating surface is from about 0.01 to about 4 μg/cm2. 10. The device according to claim 1, wherein the ratio of palladium to non-palladium metals in said metal particles is from about 0.01:99.99 to about 99.99:0.01. 11. The device according to claim 1, wherein the ratio of palladium to non-palladium metals in said metal particles is from about 0.5:99.5 to about 99.8:0.2. 12. The device according to claim 1, wherein the ratio of palladium to non-palladium metals in said metal particles is from about 2:98 to about 95:5. 13. The device according to claim 1 wherein said metal particles, comprise palladium and gold. 14. The device according to claim 1, wherein said metal particles have an average size of about 10-10000 Å. 15. The device according to claim 1, wherein said metal particles have an average size of about 100-600 Å. 16. The device according to claim 1, wherein said device is a contact lens. 17. The device according to claim 1, wherein said device is a pacemaker. 18. The device according to claim 1, wherein said device is a stent. 19. The device according to claim 1, wherein said device is a dental implant. 20. The device according to claim 1, wherein said device is a rupture net. 21. The device according to claim 1, wherein said device is a blood centrifuge equipment. 22. The device according to claim 1, wherein said device is a surgical instrument. 23. The device according to claim 1, wherein said device is a glove. 24. The device according to claim 1, wherein said device is a blood bag. 25. The device according to claim 1, wherein said device is an artificial blood valve. 26. The device according to claim 1, wherein said device is a central venous catheter. 27. The device according to claim 1, wherein said device is a peripheral venous catheter. 28. The device according to claim 1, wherein said device is a vascular port. 29. The device according to claim 1, wherein said device is a haemodialysis equipment. 30. The device according to claim 1, wherein said device is a peritoneal dialysis equipment. 31. The device according to claim 1, wherein said device is a plasmapheresis device. 32. The device according to claim 1, wherein said device is an inhalation drug delivery device. 33. The device according to claim 1, wherein said device is a vascular graft. 34. The device according to claim 1, wherein said device is a cardiac assist device. 35. The device according to claim 1, wherein said device is a wound dressing. 36. The device according to claim 1, wherein said device is an intermittent catheter. 37. The device according to claim 1, wherein said device is an ECG electrode. 38. The device according to claim 1, wherein said device is a peripheral stent. 39. The device according to claim 1, wherein said device is a bone replacing implant. 40. The device according to claim 1, wherein said device is an orthopaedic implant. 41. The device according to claim 1, wherein said device is an orthopaedic device. 42. The device according to claim 1, wherein said device is a tissue replacing implant. 43. The device according to claim 1, wherein said device is an interocular lens. 44. The device according to claim 1, wherein said device is a suture. 45. The device according to claim 1, wherein said device is a needle. 46. The device according to claim 1, wherein said device is a drug delivery device. 47. The device according to claim 1, wherein said device is an endotracheal tube. 48. The device according to claim 1, wherein said device is a shunt. 49. The device according to claim 1, wherein said device is a drain. 50. The device according to claim 1, wherein said device is a suction device. 51. The device according to claim 1, wherein said device is a hearing aid device. 52. The device according to claim 1, wherein said device is an urethral medical device. 53. The device according to claim 1, wherein said device is an artificial blood vessel. 54. Use of a device according to claim 1 for modifying protein adsorption to said device, comprising the step of contacting, said device with at least one protein. 55. Use of a device according to claim 1 for modifying bacterial adhesion to said device, comprising the step of contacting said device with bacteria. 56. Use of a device according to claim 1 for modifying tissue ingrowth on said device, comprising the step of contacting said device with growing tissue. 57. Use of a device according to claim 1 for modifying complement activation caused by said device, comprising contacting said device with at least a part of molecules belonging to a complement system. 58. Use of a device according to claim 1 for modifying inflammatory response caused by said device, comprising contacting said device with at least one type of cells in a living organism. 59. Use of a device according to claim 1 for modifying blood clotting caused by said device, comprising contacting said device with blood. 60. Use of a device according to claim 1 for preventing bacterial growth, comprising placing said device in an environment with risk for bacterial growth. 61. Use of a device according to claim 1 for preventing transmission of bacteria, comprising using said device in a situation with risk of transmission of bacteria. 62. Use of a device according to claim 1 for preventing nosocomial infections, comprising using said device in a hospital environment. 63. Use of a device according to claim 1 for modifying the friction coefficient of said device, comprising using said device in a way where the friction coefficient needs to be modified. 64. Use of a device according to claim 1 for modifying the surface hardness of said device, comprising using said device in a way where the surface hardness needs to be modified. 65. A method for the manufacture of a device comprising a substrate according to claim 1 said method comprising the steps: a. depositing metal particles from a suspension onto said substrate,b. rinsing said substrate, andc. drying said substrate. 66. The method according to claim 65 further comprising the step of depositing an electron donating material on said substrate before the deposition of metal particles.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (17)
Burrell Robert Edward (Sherwood Park CAX) Rosenfeld Aron Marcus (Kingston CAX) Smith Timothy J. N. (Kingston CAX), Actively sterile surfaces.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.